Celgene Corp (CELG.O) Analysts | Reuters.com
Edition:
United States

Celgene Corp (CELG.O)

CELG.O on Nasdaq

97.28USD
28 Jun 2016
Change (% chg)

$2.43 (+2.56%)
Prev Close
$94.85
Open
$96.26
Day's High
$97.75
Day's Low
$96.06
Volume
5,482,299
Avg. Vol
4,748,773
52-wk High
$140.72
52-wk Low
$92.98

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 1.38 December 28 Jun 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 9 10 10 11
(2) OUTPERFORM 10 10 10 9
(3) HOLD 5 4 4 4
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.92 1.84 1.84 1.80

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 20 2,698.35 2,805.50 2,629.78 2,937.66
Quarter Ending Sep-16 20 2,798.88 2,916.70 2,732.00 3,107.88
Year Ending Dec-16 23 10,985.40 11,364.00 10,784.30 11,212.70
Year Ending Dec-17 23 13,025.60 13,634.00 12,514.00 13,299.50
Earnings (per share)
Quarter Ending Jun-16 23 1.38 1.48 1.17 1.61
Quarter Ending Sep-16 23 1.46 1.55 1.38 1.74
Year Ending Dec-16 24 5.69 5.81 5.50 6.18
Year Ending Dec-17 25 7.00 7.43 6.77 7.77
LT Growth Rate (%) 10 21.77 25.00 18.00 25.27

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 2,577.39 2,511.60 65.79 2.55
Quarter Ending Dec-15 2,544.69 2,563.30 18.61 0.73
Quarter Ending Sep-15 2,400.89 2,334.10 66.79 2.78
Quarter Ending Jun-15 2,268.54 2,277.80 9.26 0.41
Quarter Ending Mar-15 2,114.38 2,080.80 33.58 1.59
Earnings (per share)
Quarter Ending Mar-16 1.27 1.32 0.05 3.53
Quarter Ending Dec-15 1.22 1.18 0.04 3.06
Quarter Ending Sep-15 1.22 1.23 0.01 0.53
Quarter Ending Jun-15 1.20 1.23 0.03 2.84
Quarter Ending Mar-15 1.06 1.07 0.01 1.23

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 2,698.35 2,698.35 2,698.15 2,735.58 2,937.66
Quarter Ending Sep-16 2,798.88 2,798.85 2,798.29 2,824.15 3,107.88
Year Ending Dec-16 10,985.40 10,985.40 10,972.10 11,115.80 11,212.70
Year Ending Dec-17 13,025.60 13,026.10 12,988.90 13,079.40 13,299.50
Earnings (per share)
Quarter Ending Jun-16 1.38 1.38 1.38 1.41 1.61
Quarter Ending Sep-16 1.46 1.46 1.46 1.46 1.74
Year Ending Dec-16 5.69 5.68 5.58 5.69 6.18
Year Ending Dec-17 7.00 7.00 7.00 7.20 7.77

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-16 1 0 2 0
Quarter Ending Sep-16 1 0 2 0
Year Ending Dec-16 0 0 1 1
Year Ending Dec-17 0 1 2 1
Earnings
Quarter Ending Jun-16 1 0 1 0
Quarter Ending Sep-16 0 1 0 1
Year Ending Dec-16 1 0 1 0
Year Ending Dec-17 0 1 1 1

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Wright Reports
$75.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.